//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
The @US_FDA approved the protein degrader vepdegestrant for adults with previously treated ER-positive, HER2-negative advanced or metastatic breast cancer with ESR1 mutations: buff.ly/B0gPzIW
1mo
FDA approves vepdegestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
www.fda.gov
FDA approves vepdegestrant for ER-positive, HER2-negative, ESR1-mutate
American Association for Cancer Research (AACR)